Daesung Microbiological Labs. Co., Ltd. (KOSDAQ:036480)
South Korea · Delayed Price · Currency is KRW 7,870.00
-400.00 (-4.84%)
At close: Mar 31, 2026
KOSDAQ:036480 Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 598.19 | -1,769 | -679.68 | 1,703 | 865.92 |
Depreciation & Amortization | 2,540 | 1,715 | 2,862 | 2,706 | 2,538 |
Loss (Gain) From Sale of Assets | -19.04 | -16.26 | 0.07 | -2,219 | -7 |
Loss (Gain) From Sale of Investments | 0.07 | 0.19 | 0.29 | 0.91 | 0.3 |
Loss (Gain) on Equity Investments | 38.7 | 27.7 | -36.39 | 14.6 | 4.97 |
Provision & Write-off of Bad Debts | 174.93 | 170.82 | 27.09 | 29.42 | 12.07 |
Other Operating Activities | 45.76 | 887.1 | -342.66 | 881.17 | 367.84 |
Change in Accounts Receivable | -1,403 | 229.73 | -1,130 | -103.07 | 516.13 |
Change in Inventory | 311.62 | 1,536 | -1,132 | -1,027 | -1,417 |
Change in Accounts Payable | -190.91 | -226.87 | 565.26 | 209.1 | -468.3 |
Change in Other Net Operating Assets | -686.04 | -450.67 | -1,368 | -1,039 | -209.63 |
Operating Cash Flow | 1,410 | 2,103 | -1,234 | 1,155 | 2,203 |
Operating Cash Flow Growth | -32.95% | - | - | -47.56% | -31.92% |
Capital Expenditures | -355.64 | -795.32 | -1,256 | -2,315 | -2,968 |
Sale of Property, Plant & Equipment | 19.05 | 18.64 | 59.09 | 4,572 | 7 |
Sale (Purchase) of Intangibles | -2.45 | -0.55 | -3.96 | -0.39 | -0.8 |
Investment in Securities | -322.85 | 2,197 | 1,437 | -3,415 | -678.96 |
Other Investing Activities | 0 | - | - | 0 | 0 |
Investing Cash Flow | -661.89 | 1,419 | 235.73 | -1,158 | -3,641 |
Short-Term Debt Issued | 1,500 | 1,000 | 3,319 | 2,000 | 700 |
Long-Term Debt Issued | - | 15,500 | 3,000 | - | 800 |
Total Debt Issued | 1,500 | 16,500 | 6,319 | 2,000 | 1,500 |
Short-Term Debt Repaid | -1,000 | -5,319 | - | -700 | -700 |
Long-Term Debt Repaid | -1,038 | -15,374 | -4,553 | -1,661 | -172.18 |
Total Debt Repaid | -2,038 | -20,692 | -4,553 | -2,361 | -872.18 |
Net Debt Issued (Repaid) | -537.86 | -4,192 | 1,766 | -361.29 | 627.82 |
Dividends Paid | -285 | -285 | -285 | -285 | -323 |
Other Financing Activities | - | - | - | - | -0 |
Financing Cash Flow | -822.86 | -4,477 | 1,481 | -646.29 | 304.82 |
Foreign Exchange Rate Adjustments | -110.12 | 222.84 | 28.2 | 105.91 | 316.07 |
Miscellaneous Cash Flow Adjustments | -0 | 0 | 0 | - | 0 |
Net Cash Flow | -184.76 | -731.96 | 510.68 | -543.44 | -816.59 |
Free Cash Flow | 1,054 | 1,308 | -2,490 | -1,160 | -764.71 |
Free Cash Flow Growth | -19.37% | - | - | - | - |
Free Cash Flow Margin | 4.06% | 5.49% | -9.74% | -4.55% | -3.19% |
Free Cash Flow Per Share | - | 344.14 | -655.25 | -305.18 | -201.24 |
Cash Interest Paid | 592.29 | 909.4 | 955.25 | 458.48 | 271.46 |
Cash Income Tax Paid | -6.08 | -52.12 | 475.4 | 46.03 | -94.73 |
Levered Free Cash Flow | 652.32 | 1,543 | -1,862 | -997.53 | -1,065 |
Unlevered Free Cash Flow | 1,031 | 2,072 | -1,304 | -677.16 | -891.44 |
Change in Working Capital | -1,969 | 1,088 | -3,065 | -1,961 | -1,579 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.